Evidence map›Paper›PMID 30561421›Full record

ReviewActa bio-medica : Atenei Parmensis2018

Helicobacter pylori, transmission routes and recurrence of infection: state of the art.

Stefano Kayali, Marco Manfredi, Federica Gaiani, Laura Bianchi, Barbara Bizzarri, Gioacchino Leandro, Francesco Di Mario, Gian Luigi De' Angelis

Open access · greenAbstract readReview
In one paragraph

Review in Acta bio-medica : Atenei Parmensis, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 113 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
113citing papers in PubMed, 2 pooled it
8.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

113 citing papers in PubMed, 2 syntheses or guidelines pooled it, 208 citations in OpenAlex.

  1. Pooled it
  2. Prevalence ofFrontiers in oncology · 2022
    Pooled it
  3. Trial
  4. Article
  5. Prevalence ofJGH open : an open access journal of gastroenterology and hepatology · 2026
    Article
  6. Ergosterol from Yeasts PromotesInternational journal of molecular sciences · 2026
    Article
  7. Article
  8. Managing dangerous liaisons: lessons fromJournal of bacteriology · 2026
    Review
  9. Correlation analysis ofFrontiers in cellular and infection microbiology · 2026
    Article
  10. Review
  11. Review
  12. Frontiers in pediatrics · 2026
    Article
  13. Article
  14. Article
  15. Current concepts of Helicobacter pylori infection.European journal of medical research · 2025
    Review
  16. BeyondMedicina (Kaunas, Lithuania) · 2025
    Review
  17. On the Role of Food in the Transmission ofFoods (Basel, Switzerland) · 2025
    Review
  18. Article
  19. Article
  20. Correlation betweenMicrobiology spectrum · 2025
    Article

53 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Stefano KayaliGastroenterology and Endoscopy Unit, Department of Medicine and Surgery, University of Parma, Parma, Italy. federica.gaiani@studenti.unipr.it.
Marco Manfredi
Federica Gaiani
Laura Bianchi
Barbara Bizzarri
Gioacchino Leandro
Francesco Di Mario
Gian Luigi De' Angelis
University of Parma · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Helicobacter pylori (H. pylori) infection is one of the most common infection in humans, affecting more than half of the population. The prevalence of the infection varies widely in rural developing areas (more than 80%) compared to urban developed ones (less than 40%), as a consequence of different socioeconomic and hygienic conditions. H. pylori infection is usually acquired during childhood; infected people usually remain asymptomatic, but about 30% of individuals may develop mild to severe upper gastrointestinal diseases such as gastritis, peptic ulcer, gastric cancer or MALT lymphoma. The transmission route is not clear yet; the person-to-person transmission, especially within the same family appears to be prevalent, but also environmental contamination is possible. The eradication without a specific therapeutic regimen is very unlikely and the reinfection rate after an effective eradication therapy is quite rare. The reinfection rate will increase if there are family members affected.

Indexed as

Helicobacter pyloriAdultAnti-Bacterial AgentsChildDrug Therapy, CombinationFecesFood MicrobiologyGastric JuiceHelicobacter InfectionsHumansPrevalenceProton Pump InhibitorsRecurrenceSalivaSocioeconomic FactorsWater MicrobiologyAnti-Bacterial AgentsProton Pump Inhibitors

Identifiers

PMID30561421
PMCPMC6502203
OpenAlexW2983146542

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.